What is the evidence base for Pinealon?

Pinealon's evidence base sits at russian clinical trials; limited western data. The references on this page summarise 1 primary publication supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The sourcing / quality / procurement interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

How does Pinealon's half-life affect dosing?

Pinealon has a plasma half-life of Short plasma; durable tissue effects, which is moderate, supporting once-daily dosing in most protocols. The receptor occupancy curve under 1x daily for 10-20 day cycles dosing at 5-10 mg per dose explains the typical onset timeline for sourcing and quality-control endpoints.

Is Pinealon safe during pregnancy or breastfeeding?

Pinealon, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

What are the safety considerations for Pinealon?

Excellent. Decades of safety data in Russian research. For sourcing and quality-control use, additional considerations: baseline labs appropriate to the targeted system, mid-cycle re-check at 4–6 weeks, and end-of-cycle full re-evaluation. Pinealon's Short plasma; durable tissue effects pharmacokinetic profile and subq/intranasal administration route influence the side-effect profile in predictable ways.

What is the standard dosing protocol for Pinealon?

Conventional Pinealon dosing is 5-10 mg 1x daily for 10-20 day cycles via subq/intranasal. For sourcing and quality-control use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

What are the procurement red flags for Pinealon?

Six markers to evaluate when sourcing Pinealon: lot-specific COAs available; HPLC purity ≥98% confirmed; mass spec confirming 418 Da; endotoxin testing for SubQ-route material; physical address and regulatory disclosure on vendor site; cold-chain shipping options. Multiple missing markers = walk away. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

Home/ Compounds/ Pinealon

Pinealon

Sourcing Guide

Sourcing Pinealon from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. A Khavinson pineal-derived tripeptide of glutamate-aspartate-arginine, studied for neuroprotection and cognitive function in aged and ischemic models. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.

Sourcing / Quality / Procurement Applications

Storage ProtocolVendor ComparisonGMP vs Research GradeRed Flag DetectionReconstitution Guide

Key Takeaways

Procurement lens: Pinealon sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 418 Da.
Mechanism: Penetrates cells, enters the nucleus, and modulates gene expression.
Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days.
Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger).
Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.

Sourcing / Quality / Procurement Mechanism

Penetrates cells, enters the nucleus, and modulates gene expression. Reduces apoptosis in stress conditions. Protects neurons from glutamate excitotoxicity. Part of the broader Khavinson bioregulator framework where short peptides serve as tissue-specific transcriptional regulators. Quality control discipline for Pinealon starts with mechanism understanding: which assays detect counterfeits, which impurities matter for the intended use, and which storage conditions preserve activity. The subsections work through HPLC purity, COA evaluation, reconstitution protocol, and vendor selection.

Vendor tier comparison and price discipline

Three vendor tiers operate in the Pinealon market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.

HPLC purity and analytical identity

Minimum acceptable HPLC purity for Pinealon is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of 418 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.

COA evaluation and red flags

Acceptable Pinealon certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.

Sourcing / Quality / Procurement Applications

Cold Chain

Sourcing Pinealon for cold chain use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Regulatory Sourcing

Pharmaceutical-grade compounded Pinealon is the lowest-risk sourcing path for regulatory sourcing use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.

COA Review

For users targeting coa review, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.

Pricing Analysis

Sourcing Pinealon for pricing analysis use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	5-10 mg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	3-10 mg	4–6 weeks initial cycle
Sourcing Guide focus	SubQ	5-10 mg	1x daily for 10-20 day cycles
Maintenance phase	SubQ	4-10 mg	Ongoing with periodic pauses

Dose timing for Pinealon is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

Pinealon stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.

Pinealon + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Pinealon's mechanism in sourcing / quality / procurement protocols.
Pinealon + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Pinealon's mechanism in sourcing / quality / procurement protocols.
Pinealon + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with Pinealon's mechanism in sourcing / quality / procurement protocols.
Pinealon + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Pinealon's mechanism in sourcing / quality / procurement protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved Research: Russian clinical trials; limited Western data

Excellent. Decades of safety data in Russian research.

Lens-specific safety considerations for sourcing / quality / procurement use of Pinealon: Excellent. Decades of safety data in Russian research. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Pinealon — neuroprotective peptide

PMID 21424325

Pinealon vs Related Peptides

Compound	Profile	Onset	Best For
Pinealon	Khavinson tripeptide (pineal-derived)	Short plasma; durable tissue effects	Sourcing Guide
BPC-157	Stable gastric pentadecapeptide	~4 hr (oral)	Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling
TB-500	Synthetic thymosin β4 fragment	~2-3 days	A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite

Frequently Asked Questions

What should I check on a Pinealon COA?

Acceptable certificates: lot-specific (not template), HPLC purity ≥98%, mass spec confirmation matching 418 Da, endotoxin testing for injectable routes, accredited third-party lab issuance. Template COAs and missing endotoxin data are red flags.

Storage protocol?

Lyophilised: −20°C for 18–24 months. Reconstituted with bacteriostatic water: 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Cold-chain shipping is preferred for purchases; insulated packaging without active cooling is acceptable for shorter transit windows.

Reconstitution best practices?

Use sterile bacteriostatic water (0.9% benzyl alcohol). Inject the BAC water down the side of the vial, not directly onto the lyophilised powder. Allow gentle dissolution; do not shake vigorously — swirl the vial. Label the reconstituted vial with concentration and date.

Pharmaceutical-grade versus research-grade?

Pharmaceutical-grade is GMP-manufactured, COA-backed, prescription-dispensed material with comprehensive quality assurance. Research-grade is laboratory-purpose, COA-backed, not dispensed under prescription. Quality varies substantially between research-grade vendors; pharmaceutical-grade has a tighter quality distribution and a higher price.

What is the regulatory status of Pinealon?

Pinealon regulatory status: Unapproved in the United States; WADA status not on prohibited list; research level russian clinical trials; limited western data. Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For sourcing and quality-control use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

Should I cycle Pinealon?

Standard cycle for Pinealon is 8–12 weeks of 1x daily for 10-20 day cycles 5-10 mg dosing via subq/intranasal, followed by a 4 week complete off-period. The off-period is calibrated to Pinealon's Short plasma; durable tissue effects half-life and to typical receptor downregulation timelines. Continuous indefinite dosing does not show additional clinical benefit in the published literature and increases cumulative downregulation risk.

Clinical Protocol

Start a Pinealon Protocol

Alukard provides GMP-certified physician-supervised sourcing with GMP-certified Pinealon and Pharmaceutical-grade compounds with full COA documentation.

Get Protocol

Quick Facts

Molecular weight: 418 Da
Sequence length: 3 aa
Half-life: Short plasma; durable tissue effects
WADA: Not on prohibited list
FDA: Unapproved
Research: Russian clinical trials; limited Western data

Stack Partners

BPC-157

TB-500

GHK-Cu

Ipamorelin

Semax

Research Note

All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Pinealon unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

GMP-certified physician-supervised sourcing

Start Your Sourcing / Quality / Procurement Protocol for Pinealon

Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised